(Webinar Held: December 16, 2019) The HDA Research Foundation partnered with Rutgers University’s Business School for the fall 2019 semester.
Through panel interviews and a survey with manufacturers, distributors and dispensers, a team of four graduate students explored how elements of the Drug Supply Chain Security Act (DSCSA) will extend into the broader healthcare system. The study identified common business functions and processes that could be affected once additional requirements are incorporated, what those outcomes may be and whether any efficiencies may be gained as each sector evolves and full traceability is implemented in 2023.
Read the accompanying whitepaper.
This project was sponsored by: IQVIA